A new heart drug could be a   but it comes with a high price: $14, 523 a year. Those who took the drug Repatha were significantly less likely to have heart attacks or strokes, researchers found in a new study. The drug, manufactured by Amgen, has the potential to help millions of Americans with heart disease, which is the nationâ€™s leading killer. Robert Johnson, above with his daughters, says he feels "much safer" taking the drug. 